Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 202

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028



The global immunohistochemistry market is projected to reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer and vast application of IHC test in the diagnosis and management of cancer. Also, development for companion diagnostics and the integration of companion diagnostics with IHC is facilitating personalized medicine, supporting drug development and approval processes, expanding market potential, improves patient outcomes, encouraging research collaboration, and providing growth opportunities for Immunohistochemistry Market.

Histological Stain is expected to account for the largest share for by reagents segment.

In 2022, immunohistochemistry histological stains market accounted for the largest share. In immunohistochemistry, the relative localization of the target can be obtained by visualizing all relative targets in one slide with the help of multiple staining techniques. Multiple staining is the detection of two or more targets on a single slide, and it can be done by sequential staining, simultaneous staining, and multi-step staining using dyes. Hence, the advanced ability to multiplex antigenic sites in a single tissue section presents an experimental and ease-of-use advantage, which is expected to drive the market for histological stains.

Research applications segment accounted for the second-largest share of the application segment

In 2022, research applications accounted for the second largest share. IHC in research applications includes anti-tumor drug development and biomarker discovery. IHC helps to investigate the expression of specific proteins and co-localization of proteins within the membrane, cytoplasm, or nucleus to study the altered expression in normal and abnormal cells, more specifically to investigate the cancer proteome. High-throughput automated IHC platforms used in research applications help to maintain the uniformity of staining between slides. Due to these advantages, IHC techniques are also widely used in developmental (embryological) studies, stem cell research, and drug testing.

Asia Pacific is the fastest growing region in the immunohistochemistry market

The immunohistochemistry market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). Asia Pacific is the fastest growing region in as it is a high-growth market, which is characterized by the fast adoption of the latest technologically advanced products (like assays and diagnostic kits) in research and clinical applications. This factor, coupled with the increasing geriatric population in the region are the key drivers for fast growth rate.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side - 30%

By Designation: Managers - 55%, CXOs - 20%, and Executives - 25%

By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Prominent Players of the Immunohistochemistry market are F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US).

Research Coverage:

This report provides a detailed picture of the immunohistochemistry market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall immunohistochemistry market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, challenges and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Rising geriatric population and growing prevalence of cancer diseases to influence positive market growth, Technological advancements in IHC, Availability of reimbursements for IHC tests, and Adoption of digital pathology fueling the market growth), restraint (Availability of alternative technologies, High degree of consolidation), opportunities (Increasing demand for personalized medicine, Growing significance of companion diagnostics, Growth opportunities in emerging countries, and Application of Artificial intelligence in IHC), Challenges (Product failures and recalls, Stringent regulatory requirements, Lack of Standardization)

Product Development/Innovation: Detailed insights on newly launched product, and technological assessment of the Immunohistochemistry market.

Market Development: Comprehensive information about lucrative markets – the report analyses the Immunohistochemistry market across varied regions.

Market Diversification: Exhaustive information about new product, untapped geographies, recent developments, and investments in the Immunohistochemistry market.

Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US) among others in the Immunohistochemistry market. The report also helps stakeholders understand the pulse of IHC market and provides them information on key market drivers, restraints, challenges, and opportunities.


1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
Table 1 Immunohistochemistry Market: Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Immunohistochemistry Market Segmentation
1.3.2 Years Considered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes
1.7.1 Recession Impact
2 Research Methodology
2.1 Research Data
Figure 2 Ihc Market: Research Design Methodology
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 3 Ihc Market: Breakdown Of Primaries
2.2 Market Estimation Methodology
Figure 4 Ihc Market Size Estimation (Supply-side Analysis), 2022
Figure 5 Market Size Estimation: Approach 1 (Company Revenue Analysis-based Estimation), 2022
2.2.1 Insights From Primary Experts
Figure 6 Market Size Validation From Primary Sources
2.3 Market Growth Rate Projections
Figure 7 Ihc Market (Supply Side): Cagr Projections
Figure 8 Ihc Market (Demand Side): Growth Analysis Of Demand-side Drivers
2.3.1 Data Triangulation
Figure 9 Data Triangulation Methodology
2.4 Research Assumptions
2.5 Risk Analysis
2.6 Recession Impact
Table 2 Global Inflation Rate Projections, 2021–2027 (% Growth)
Table 3 Us Health Expenditure, 2019–2022 (Usd Million)
Table 4 Us Health Expenditure, 2023–2027 (Usd Million)
3 Executive Summary
Figure 10 Immunohistochemistry Market, By Product, 2023 Vs. 2028 (Usd Million)
Figure 11 Immunohistochemistry Market Share, By Application, 2022
Figure 12 Immunohistochemistry Market, By End User, 2023 Vs. 2028
Figure 13 Immunohistochemistry Market: Regional Snapshot
4 Premium Insights
4.1 Immunohistochemistry Market Overview
Figure 14 Technological Advancements To Drive Market Growth
4.2 Asia Pacific: Immunohistochemistry Market Share, By End User And Country (2022)
Figure 15 Hospitals & Diagnostic Laboratories Segment Accounted For Largest Share Of Asia Pacific Ihc Market In 2022
4.3 Immunohistochemistry Market For Antibodies, By Type
Figure 16 Primary Antibodies Segment To Lead Ihc Antibodies Market During Forecast Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 17 Ihc Market: Drivers, Restraints, Opportunities, & Challenges
Table 5 Ihc Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population And Growing Prevalence Of Cancer
Table 6 Estimated Percentage Increase In Geriatric Population, By Region (2022–2050)
Figure 18 Cancer Incidence, By Region And Type Of Cancer, 2020
5.2.1.2 Technological Advancements In Ihc
5.2.1.3 Availability Of Reimbursements For Ihc Tests
Table 7 Cpt Codes For Ihc Procedures
5.2.1.4 Adoption Of Digital Pathology
5.2.2 Restraints
5.2.2.1 Availability Of Alternative Technologies
5.2.2.2 High Degree Of Consolidation
Table 8 Major Acquisitions In Market, 2020–2023
5.2.3 Opportunities
5.2.3.1 Increasing Demand For Personalized Medicine
Figure 19 Growth Of Personalized Medicines Approved By Fda, 2015–2022
5.2.3.2 Growing Significance Of Companion Diagnostics
5.2.3.3 Growth Opportunities In Emerging Countries
5.2.3.4 Application Of Artificial Intelligence In Ihc
5.2.4 Challenges
5.2.4.1 Product Failures And Recalls
5.2.4.2 Stringent Regulatory Requirements
5.2.4.3 Lack Of Standardization
5.3 Elements Of Uncertainty In Ihc Market
Figure 20 Ihc Market: Spectrum Of Scenarios Based On Impact Of Uncertainties On Growth
5.4 Trends/Disruptions Impacting Customers’ Businesses
Figure 21 Revenue Shift & New Revenue Pockets For Ihc Providers
5.5 Pricing Analysis
Table 9 Average Selling Price Of Some Ihc Equipment, Reagents, And Kits (2022)
5.5.1 Average Selling Price Trends
5.6 Value Chain Analysis
Figure 22 Value Chain Analysis Of Ihc Market: Raw Material And Manufacturing Phase To Contribute Maximum Value
5.6.1 Research And Product Development
5.7 Ecosystem Analysis
Figure 23 Ihc Market: Ecosystem Analysis
Table 10 Supply Chain Ecosystem
5.8 Technology Analysis
5.9 Patent Analysis
Figure 24 Ihc Market: Patent Analysis, 2014–2023
Table 11 Indicative List Of Patents In Ihc Market
5.10 Regulatory Analysis
5.10.1 Us
Table 12 Us: Classification Of In Vitro Diagnostic Devices
Figure 25 Us: Regulatory Process For Ivd Devices
5.10.2 Canada
Figure 26 Canada: Regulatory Process For Ivd Devices
5.10.3 Europe
Table 13 Europe: Classification Of Ivd Devices
Figure 27 Europe: Regulatory Process For Ivd Devices
5.10.4 Japan
Figure 28 Japan: Regulatory Process For Ivd Devices
Table 14 Japan: Classification Of Ivd Reagents
Table 15 Japan: Time, Cost, And Complexity Of Registration Process
5.10.5 China
Table 16 China: Time, Cost, And Complexity Of Registration Process
5.10.6 India
Figure 29 India: Regulatory Process For Ivd Devices
5.10.7 Brazil
Figure 30 Brazil: Regulatory Process For Ivd Devices
5.11 Porter’s Five Forces Analysis
Table 17 Impact Of Porter’s Five Forces Analysis On Ihc Market
5.11.1 Threat Of New Entrants
5.11.2 Threat Of Substitutes
5.11.3 Bargaining Power Of Buyers
5.11.4 Bargaining Power Of Suppliers
5.11.5 Intensity Of Competitive Rivalry
5.12 Key Conferences And Events In 2023–2024
Table 18 Immunohistochemistry Market: List Of Conferences And Events
5.13 Key Stakeholders And Buying Criteria
Figure 31 Influence Of Stakeholders On Buying Process Of Immunohistochemistry Products
Figure 32 Buying Criteria For Immunohistochemistry Products
6 Immunohistochemistry Market, By Product
6.1 Introduction
Table 19 Immunohistochemistry Market, By Product, 2021–2028 (Usd Million)
6.2 Antibodies
Table 20 Immunohistochemistry Market For Antibodies, By Region, 2021–2028 (Usd Million)
Table 21 North America: Immunohistochemistry Market For Antibodies, By Country, 2021–2028 (Usd Million)
Table 22 Europe: Immunohistochemistry Market For Antibodies, By Country, 2021–2028 (Usd Million)
Table 23 Asia Pacific: Immunohistochemistry Market For Antibodies, By Country, 2021–2028 (Usd Million)
Table 24 Immunohistochemistry Market For Antibodies, By Type, 2021–2028 (Usd Million)
6.2.1 Primary Antibodies
6.2.1.1 Wide Applications In Diagnostics And Research To Support Demand For Primary Antibodies
Table 25 Immunohistochemistry Market For Primary Antibodies, By Region, 2021–2028 (Usd Million)
Table 26 North America: Immunohistochemistry Market For Primary Antibodies, By Country, 2021–2028 (Usd Million)
Table 27 Europe: Immunohistochemistry Market For Primary Antibodies, By Country, 2021–2028 (Usd Million)
Table 28 Asia Pacific: Immunohistochemistry Market For Primary Antibodies, By Country, 2021–2028 (Usd Million)
6.2.2 Secondary Antibodies
6.2.2.1 Signal Amplification Through Conjugation And Comparatively Easy Manufacturing To Fuel Market
Table 29 Immunohistochemistry Market For Secondary Antibodies, By Region, 2021–2028 (Usd Million)
Table 30 North America: Immunohistochemistry Market For Secondary Antibodies, By Country, 2021–2028 (Usd Million)
Table 31 Europe: Immunohistochemistry Market For Secondary Antibodies, By Country, 2021–2028 (Usd Million)
Table 32 Asia Pacific: Immunohistochemistry Market For Secondary Antibodies, By Country, 2021–2028 (Usd Million)
6.3 Reagents
Table 33 Immunohistochemistry Market For Reagents, By Region, 2021–2028 (Usd Million)
Table 34 North America: Immunohistochemistry Market For Reagents, By Country, 2021–2028 (Usd Million)
Table 35 Europe: Immunohistochemistry Market For Reagents, By Country, 2021–2028 (Usd Million)
Table 36 Asia Pacific: Immunohistochemistry Market For Reagents, By Country, 2021–2028 (Usd Million)
Table 37 Immunohistochemistry Market For Reagents, By Type, 2021–2028 (Usd Million)
6.3.1 Histological Stains
6.3.1.1 Developments In Concurrent Detection Of Multiple Antigenic Sites And Cancer Disease Progression Studies To Propel Market
Table 38 Immunohistochemistry Market For Histological Stains, By Region, 2021–2028 (Usd Million)
Table 39 North America: Immunohistochemistry Market For Histological Stains, By Country, 2021–2028 (Usd Million)
Table 40 Europe: Immunohistochemistry Market For Histological Stains, By Country, 2021–2028 (Usd Million)
Table 41 Asia Pacific: Immunohistochemistry Market For Histological Stains, By Country, 2021–2028 (Usd Million)
6.3.2 Blocking Sera And Reagents
6.3.2.1 Blocking Sera And Reagents To Prevent Nonspecific Binding And Reduce Background Noise & Potentially False-positive Results
Table 42 Immunohistochemistry Market For Blocking Sera And Reagents, By Region, 2021–2028 (Usd Million)
Table 43 North America: Immunohistochemistry Market For Blocking Sera And Reagents, By Country, 2021–2028 (Usd Million)
Table 44 Europe: Immunohistochemistry Market For Blocking Sera And Reagents, By Country, 2021–2028 (Usd Million)
Table 45 Asia Pacific: Immunohistochemistry Market For Blocking Sera And Reagents, By Country, 2021–2028 (Usd Million)
6.3.3 Chromogenic Substrates
6.3.3.1 Chromogenic Substrates Segment To Register Highest Growth During Forecast Period
Table 46 Immunohistochemistry Market For Chromogenic Substrates, By Region, 2021–2028 (Usd Million)
Table 47 North America: Immunohistochemistry Market For Chromogenic Substrates, By Country, 2021–2028 (Usd Million)
Table 48 Europe: Immunohistochemistry Market For Chromogenic Substrates, By Country, 2021–2028 (Usd Million)
Table 49 Asia Pacific: Immunohistochemistry Market For Chromogenic Substrates, By Country, 2021–2028 (Usd Million)
6.3.4 Fixation Reagents
6.3.4.1 North America Projected To Be Largest Market For Fixation Reagents
Table 50 Immunohistochemistry Market For Fixation Reagents, By Region, 2021–2028 (Usd Million)
Table 51 North America: Immunohistochemistry Market For Fixation Reagents, By Country, 2021–2028 (Usd Million)
Table 52 Europe: Immunohistochemistry Market For Fixation Reagents, By Country, 2021–2028 (Usd Million)
Table 53 Asia Pacific: Immunohistochemistry Market For Fixation Reagents, By Country, 2021–2028 (Usd Million)
6.3.5 Diluents
6.3.5.1 Need Of Diluents For Preparation Of Antibody Solutions To Promote Market Growth
Table 54 Immunohistochemistry Market For Diluents, By Region, 2021–2028 (Usd Million)
Table 55 North America: Immunohistochemistry Market For Diluents, By Country, 2021–2028 (Usd Million)
Table 56 Europe: Immunohistochemistry Market For Diluents, By Country, 2021–2028 (Usd Million)
Table 57 Asia Pacific: Immunohistochemistry Market For Diluents, By Country, 2021–2028 (Usd Million)
6.3.6 Organic Solvents
6.3.6.1 Organic Solvents To Prevent Physical Damage In Specimens And Improve Clarity While Visualizing Tissue Samples
Table 58 Immunohistochemistry Market For Organic Solvents, By Region, 2021–2028 (Usd Million)
Table 59 North America: Immunohistochemistry Market For Organic Solvents, By Country, 2021–2028 (Usd Million)
Table 60 Europe: Immunohistochemistry Market For Organic Solvents, By Country, 2021–2028 (Usd Million)
Table 61 Asia Pacific: Immunohistochemistry Market For Organic Solvents, By Country, 2021–2028 (Usd Million)
6.3.7 Proteolytic Enzymes
6.3.7.1 Proteolytic Enzymes Improve Accessibility Of Target Antibodies
Table 62 Immunohistochemistry Market For Proteolytic Enzymes, By Region, 2021–2028 (Usd Million)
Table 63 North America: Immunohistochemistry Market For Proteolytic Enzymes, By Country, 2021–2028 (Usd Million)
Table 64 Europe: Immunohistochemistry Market For Proteolytic Enzymes, By Country, 2021–2028 (Usd Million)
Table 65 Asia Pacific: Immunohistochemistry Market For Proteolytic Enzymes, By Country, 2021–2028 (Usd Million)
6.3.8 Other Reagents
Table 66 Immunohistochemistry Market For Other Reagents, By Region, 2021–2028 (Usd Million)
Table 67 North America: Immunohistochemistry Market For Other Reagents, By Country, 2021–2028 (Usd Million)
Table 68 Europe: Immunohistochemistry Market For Other Reagents, By Country, 2021–2028 (Usd Million)
Table 69 Asia Pacific: Immunohistochemistry Market For Other Reagents, By Country, 2021–2028 (Usd Million)
6.4 Equipment
Table 70 Immunohistochemistry Market For Equipment, By Region, 2021–2028 (Usd Million)
Table 71 North America: Immunohistochemistry Market For Equipment, By Country, 2021–2028 (Usd Million)
Table 72 Europe: Immunohistochemistry Market For Equipment, By Country, 2021–2028 (Usd Million)
Table 73 Asia Pacific: Immunohistochemistry Market For Equipment, By Country, 2021–2028 (Usd Million)
Table 74 Immunohistochemistry Market For Equipment, By Type, 2021–2028 (Usd Million)
6.4.1 Slide-staining Systems
6.4.1.1 Development Of High-throughput Staining Systems To Drive Market Growth
Table 75 Immunohistochemistry Market For Slide-staining Systems, By Region, 2021–2028 (Usd Million)
Table 76 North America: Immunohistochemistry Market For Slide-staining Systems, By Country, 2021–2028 (Usd Million)
Table 77 Europe: Immunohistochemistry Market For Slide-staining Systems, By Country, 2021–2028 (Usd Million)
Table 78 Asia Pacific: Immunohistochemistry Market For Slide-staining Systems, By Country, 2021–2028 (Usd Million)
6.4.2 Tissue Processing Systems
6.4.2.1 Technological Advancements And Need For Automation Due To Lack Of Skilled Workforce To Fuel Market
Table 79 Immunohistochemistry Market For Tissue Processing Systems, By Region, 2021–2028 (Usd Million)
Table 80 North America: Immunohistochemistry Market For Tissue Processing Systems, By Country, 2021–2028 (Usd Million)
Table 81 Europe: Immunohistochemistry Market For Tissue Processing Systems, By Country, 2021–2028 (Usd Million)
Table 82 Asia Pacific: Immunohistochemistry Market For Tissue Processing Systems, By Country, 2021–2028 (Usd Million)
6.4.3 Slide Scanners
6.4.3.1 Development Of Advanced Multiplexed Ihc Scanners To Drive Market Growth
Table 83 Immunohistochemistry Market For Slide Scanners, By Region, 2021–2028 (Usd Million)
Table 84 North America: Immunohistochemistry Market For Slide Scanners, By Country, 2021–2028 (Usd Million)
Table 85 Europe: Immunohistochemistry Market For Slide Scanners, By Country, 2021–2028 Usd Million)
Table 86 Asia Pacific: Immunohistochemistry Market For Slide Scanners, By Country, 2021–2028 (Usd Million)
6.4.4 Other Equipment
Table 87 Immunohistochemistry Market For Other Equipment, By Region, 2021–2028 (Usd Million)
Table 88 North America: Immunohistochemistry Market For Other Equipment, By Country, 2021–2028 (Usd Million)
Table 89 Europe: Immunohistochemistry Market For Other Equipment, By Country, 2021–2028 (Usd Million)
Table 90 Asia Pacific: Immunohistochemistry Market For Other Equipment, By Country, 2021–2028 (Usd Million)
6.5 Kits
Table 91 Immunohistochemistry Market For Kits, By Region, 2021–2028 (Usd Million)
Table 92 North America: Immunohistochemistry Market For Kits, By Country, 2021–2028 (Usd Million)
Table 93 Europe: Immunohistochemistry Market For Kits, By Country, 2021–2028 (Usd Million)
Table 94 Asia Pacific: Immunohistochemistry Market For Kits, By Country, 2021–2028 (Usd Million)
Table 95 Immunohistochemistry Market For Kits, By Type, 2021–2028 (Usd Million)
6.5.1 Human Immunohistochemistry Kits
6.5.1.1 Increasing Focus On Cancer Research To Fuel Market Growth
Table 96 Immunohistochemistry Market For Human Immunohistochemistry Kits, By Region, 2021–2028 (Usd Million)
Table 97 North America: Immunohistochemistry Market For Human Immunohistochemistry Kits, By Country, 2021–2028 (Usd Million)
Table 98 Europe: Immunohistochemistry Market For Human Immunohistochemistry Kits, By Country, 2021–2028 (Usd Million)
Table 99 Asia Pacific: Immunohistochemistry Market For Human Immunohistochemistry Kits, By Country, 2021–2028 (Usd Million)
6.5.2 Animal Immunohistochemistry Kits
6.5.2.1 Increasing Preclinical Drug Testing To Boost Market
Table 100 Immunohistochemistry Market For Animal Immunohistochemistry Kits, By Region, 2021–2028 (Usd Million)
Table 101 North America: Immunohistochemistry Market For Animal Immunohistochemistry Kits, By Country, 2021–2028 (Usd Million)
Table 102 Europe: Immunohistochemistry Market For Animal Immunohistochemistry Kits, By Country, 2021–2028 (Usd Million)
Table 103 Asia Pacific: Immunohistochemistry Market For Animal Immunohistochemistry Kits, By Country, 2021–2028 (Usd Million)
7 Immunohistochemistry Market, By Application
7.1 Introduction
Table 104 Immunohistochemistry Market, By Application, 2021–2028 (Usd Million)
7.2 Diagnostic Applications
Table 105 Immunohistochemistry Market For Diagnostic Applications, By Region, 2021–2028 (Usd Million)
Table 106 North America: Immunohistochemistry Market For Diagnostic Applications, By Country, 2021–2028 (Usd Million)
Table 107 Europe: Immunohistochemistry Market For Diagnostic Applications, By Country, 2021–2028 (Usd Million)
Table 108 Asia Pacific: Immunohistochemistry Market For Diagnostic Applications, By Country, 2021–2028 (Usd Million)
Table 109 Immunohistochemistry Market For Diagnostic Applications, By Disease, 2021–2028 (Usd Million)
7.2.1 Cancer
7.2.1.1 Rise In Incidence Rate Of Cancer And Growing Use Of Ihc Tests For Cancer Diagnostics To Drive Market
Table 110 Common Cancer Markers For Immunohistochemical Diagnosis
Table 111 Immunohistochemistry Market For Cancer, By Region, 2021–2028 (Usd Million)
Table 112 North America: Immunohistochemistry Market For Cancer, By Country, 2021–2028 (Usd Million)
Table 113 Europe: Immunohistochemistry Market For Cancer, By Country, 2021–2028 (Usd Million)
Table 114 Asia Pacific: Immunohistochemistry Market For Cancer, By Country, 2021–2028 (Usd Million)
7.2.2 Infectious Diseases
7.2.2.1 Growing Prevalence Of Infectious Diseases And Rising Awareness Of Early Diagnosis To Propel Market
Table 115 Common Infectious Disease Markers/Antigens For Immunohistochemical Diagnosis
Table 116 Immunohistochemistry Market For Infectious Diseases, By Region, 2021–2028 (Usd Million)
Table 117 North America: Immunohistochemistry Market For Infectious Diseases, By Country, 2021–2028 (Usd Million)
Table 118 Europe: Immunohistochemistry Market For Infectious Diseases, By Country, 2021–2028 (Usd Million)
Table 119 Asia Pacific: Immunohistochemistry Market For Infectious Diseases, By Country, 2021–2028 (Usd Million)
7.2.3 Nephrological Diseases
7.2.3.1 Wide Application Of Ihc In Transplant Rejection Expected To Support Market Growth
Table 120 Immunohistochemistry Market For Nephrological Diseases, By Region, 2021–2028 (Usd Million)
Table 121 North America: Immunohistochemistry Market For Nephrological Diseases, By Country, 2021–2028 (Usd Million)
Table 122 Europe: Immunohistochemistry Market For Nephrological Diseases, By Country, 2021–2028 (Usd Million)
Table 123 Asia Pacific: Immunohistochemistry Market For Nephrological Diseases, By Country, 2021–2028 (Usd Million)
7.2.4 Autoimmune Diseases
7.2.4.1 Availability Of Numerous Primary Antibodies And Rapid Processing Of Results To Drive Market
Table 124 Immunohistochemistry Market For Autoimmune Diseases, By Region, 2021–2028 (Usd Million)
Table 125 North America: Immunohistochemistry Market For Autoimmune Diseases, By Country, 2021–2028 (Usd Million)
Table 126 Europe: Immunohistochemistry Market For Autoimmune Diseases, By Country, 2021–2028 (Usd Million)
Table 127 Asia Pacific: Immunohistochemistry Market For Autoimmune Diseases, By Country, 2021–2028 (Usd Million)
7.2.5 Neurological Diseases
7.2.5.1 Increasing Global Burden Of Neurological Diseases To Propel Market Growth
Table 128 Common Immunohistochemistry Markers For Central Nervous System
Table 129 Immunohistochemistry Market For Neurological Diseases, By Region, 2021–2028 (Usd Million)
Table 130 North America: Immunohistochemistry Market For Neurological Diseases, By Country, 2021–2028 (Usd Million)
Table 131 Europe: Immunohistochemistry Market For Neurological Diseases, By Country, 2021–2028 (Usd Million)
Table 132 Asia Pacific: Immunohistochemistry Market For Neurological Diseases, By Country, 2021–2028 (Usd Million)
7.2.6 Other Diseases
Table 133 Immunohistochemistry Market For Other Diseases, By Region, 2021–2028 (Usd Million)
Table 134 North America: Immunohistochemistry Market For Other Diseases, By Country, 2021–2028 (Usd Million)
Table 135 Europe: Immunohistochemistry Market For Other Diseases, By Country, 2021–2028 (Usd Million)
Table 136 Asia Pacific: Immunohistochemistry Market For Other Diseases, By Country, 2021–2028 (Usd Million)
7.3 Research Applications
Table 137 Immunohistochemistry Market For Research Applications, By Region, 2021–2028 (Usd Million)
Table 138 North America: Immunohistochemistry Market For Research Applications, By Country, 2021–2028 (Usd Million)
Table 139 Europe: Immunohistochemistry Market For Research Applications, By Country, 2021–2028 (Usd Million)
Table 140 Asia Pacific: Immunohistochemistry Market For Research Applications, By Country, 2021–2028 (Usd Million)
Table 141 Immunohistochemistry Market For Research Applications, By Type, 2021–2028 (Usd Million)
7.3.1 Drug Development & Testing
7.3.1.1 Quantitative Image Analysis Makes Ihc Techniques Ideal For Drug Testing
Table 142 Immunohistochemistry Market For Drug Development & Testing, By Region, 2021–2028 (Usd Million)
Table 143 North America: Immunohistochemistry Market For Drug Development & Testing, By Country, 2021–2028 (Usd Million)
Table 144 Europe: Immunohistochemistry Market For Drug Development & Testing, By Country, 2021–2028 (Usd Million)
Table 145 Asia Pacific: Immunohistochemistry Market For Drug Development & Testing, By Country, 2021–2028 (Usd Million)
7.3.2 Other Research Applications
Table 146 Immunohistochemistry Market For Other Research Applications, By Region, 2021–2028 (Usd Million)
Table 147 North America: Immunohistochemistry Market For Other Research Applications, By Country, 2021–2028 (Usd Million)
Table 148 Europe: Immunohistochemistry Market For Other Research Applications, By Country, 2021–2028 (Usd Million)
Table 149 Asia Pacific: Immunohistochemistry Market For Other Research Applications, By Country, 2021–2028 (Usd Million)
7.4 Forensic Applications
Table 150 Immunohistochemistry Market For Forensic Applications, By Region, 2021–2028 (Usd Million)
Table 151 North America: Immunohistochemistry Market For Forensic Applications, By Country, 2021–2028 (Usd Million)
Table 152 Europe: Immunohistochemistry Market For Forensic Applications, By Country, 2021–2028 (Usd Million)
Table 153 Asia Pacific: Immunohistochemistry Market For Forensic Applications, By Country, 2021–2028 (Usd Million)
8 Immunohistochemistry Market, By End User
8.1 Introduction
Table 154 Immunohistochemistry Market, By End User, 2021–2028 (Usd Million)
8.2 Hospitals & Diagnostic Laboratories
8.2.1 Rise In Specialty Diagnostic Tests In Laboratories And In-house Diagnostic Procedures In Hospitals To Drive Market
Table 155 Immunohistochemistry Market For Hospitals & Diagnostic Laboratories, By Region, 2021–2028 (Usd Million)
Table 156 North America: Immunohistochemistry Market For Hospitals & Diagnostic Laboratories, By Country, 2021–2028 (Usd Million)
Table 157 Europe: Immunohistochemistry Market For Hospitals & Diagnostic Laboratories, By Country, 2021–2028 (Usd Million)
Table 158 Asia Pacific: Immunohistochemistry Market For Hospitals & Diagnostic Laboratories, By Country, 2021–2028 (Usd Million)
8.3 Academic & Research Institutes
8.3.1 Growing Application Of Ihc Tests For Drug Development Studies To Positively Impact Market Growth
Table 159 Immunohistochemistry Market For Academic & Research Institutes, By Region, 2021–2028 (Usd Million)
Table 160 North America: Immunohistochemistry Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million)
Table 161 Europe: Immunohistochemistry Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million)
Table 162 Asia Pacific: Immunohistochemistry Market For Academic & Research Institutes, By Country, 2021–2028 (Usd Million)
8.4 Other End Users
Table 163 Immunohistochemistry Market For Other End Users, By Region, 2021–2028 (Usd Million)
Table 164 North America: Immunohistochemistry Market For Other End Users, By Country, 2021–2028 (Usd Million)
Table 165 Europe: Immunohistochemistry Market For Other End Users, By Country, 2021–2028 (Usd Million)
Table 166 Asia Pacific: Immunohistochemistry Market For Other End Users, By Country, 2021–2028 (Usd Million)
9 Immunohistochemistry Market, By Region
9.1 Introduction
Table 167 Immunohistochemistry Market, By Region, 2021–2028 (Usd Million)
9.2 North America
Figure 33 North America: Immunohistochemistry Market Snapshot
Table 168 North America: Immunohistochemistry Market, By Country, 2021–2028 (Usd Million)
Table 169 North America: Immunohistochemistry Market, By Product, 2021–2028 (Usd Million)
Table 170 North America: Immunohistochemistry Market For Antibodies, By Type, 2021–2028 (Usd Million)
Table 171 North America: Immunohistochemistry Market For Reagents, By Type, 2021–2028 (Usd Million)
Table 172 North America: Immunohistochemistry Market For Equipment, By Type, 2021–2028 (Usd Million)
Table 173 North America: Immunohistochemistry Market For Kits, By Type, 2021–2028 (Usd Million)
Table 174 North America: Immunohistochemistry Market, By Application, 2021–2028 (Usd Million)
Table 175 North America: Immunohistochemistry Market For Diagnostic Applications, By Disease, 2021–2028 (Usd Million)
Table 176 North America: Immunohistochemistry Market For Research Applications, By Type, 2021–2028 (Usd Million)
Table 177 North America: Immunohistochemistry Market, By End User, 2021–2028 (Usd Million)
9.2.1 Us
9.2.1.1 Availability Of Reimbursements For Fda-approved Immunohistochemistry Products To Promote Market
Table 178 Recent Developments In Us Ihc Market
Table 179 Us: Immunohistochemistry Market, By Product, 2021–2028 (Usd Million)
Table 180 Us: Immunohistochemistry Market For Antibodies, By Type, 2021–2028 (Usd Million)
Table 181 Us: Immunohistochemistry Market For Reagents, By Type, 2021–2028 (Usd Million)
Table 182 Us: Immunohistochemistry Market For Equipment, By Type, 2021–2028 (Usd Million)
Table 183 Us: Immunohistochemistry Market For Kits, By Type, 2021–2028 (Usd Million)
Table 184 Us: Immunohistochemistry Market, By Application, 2021–2028 (Usd Million)
Table 185 Us: Immunohistochemistry Market For Diagnostic Applications, By Disease, 2021–2028 (Usd Million)
Table 186 Us: Immunohistochemistry Market For Research Applications, By Type, 2021–2028 (Usd Million)
Table 187 Us: Immunohistochemistry Market, By End User, 2021–2028 (Usd Million)
9.2.2 Canada
9.2.2.1 Rise In Cancer Cases In Canada To Propel Market Growth
Table 188 Canada: Immunohistochemistry Market, By Product, 2021–2028 (Usd Million)
Table 189 Canada: Immunohistochemistry Market For Antibodies, By Type, 2021–2028 (Usd Million)
Table 190 Canada: Immunohistochemistry Market For Reagents, By Type, 2021–2028 (Usd Million)
Table 191 Canada: Immunohistochemistry Market For Equipment, By Type, 2021–2028 (Usd Million)
Table 192 Canada: Immunohistochemistry Market For Kits, By Type, 2021–2028 (Usd Million)
Table 193 Canada: Immunohistochemistry Market, By Application, 2021–2028 (Usd Million)
Table 194 Canada: Immunohistochemistry Market For Diagnostic Applications, By Disease, 2021–2028 (Usd Million)
Table 195 Canada: Immunohistochemistry Market For Research Applications, By Type, 2021–2028 (Usd Million)
Table 196 Canada: Immunohistochemistry Market, By End User, 2021–2028 (Usd Million)
9.2.3 North America: Recession Impact
9.3 Europe
Table 197 Recent Developments In European Ihc Market
Table 198 Europe: Immunohistochemistry Market, By Country, 2021–2028 (Usd Million)
Table 199 Europe: Immunohistochemistry Market, By Product, 2021–2028 (Usd Million)
Table 200 Europe: Immunohistochemistry Market For Antibodies, By Type, 2021–2028 (Usd Million)
Table 201 Europe: Immunohistochemistry Market For Reagents, By Type, 2021–2028 (Usd Million)
Table 202 Europe: Immunohistochemistry Market For Equipment, By Type, 2021–2028 (Usd Million)
Table 203 Europe: Immunohistochemistry Market For Kits, By Type, 2021–2028 (Usd Million)
Table 204 Europe: Immunohistochemistry Market, By Application, 2021–2028 (Usd Million)
Table 205 Europe: Immunohistochemistry Market For Diagnostic Applications, By Disease, 2021–2028 (Usd Million)
Table 206 Europe: Immunohistochemistry Market For Research Applications, By Type, 2021–2028 (Usd Million)
Table 207 Europe: Immunohistochemistry Market, By End User, 2021–2028 (Usd Million)
9.3.1 Germany
9.3.1.1 Germany To Dominate European Ihc Market Due To Vast Research Pool And Favorable Reimbursement Policies
Table 208 Germany: Immunohistochemistry Market, By Product, 2021–2028 (Usd Million)
Table 209 Germany: Immunohistochemistry Market For Antibodies, By Type, 2021–2028 (Usd Million)
Table 210 Germany: Immunohistochemistry Market For Reagents, By Type, 2021–2028 (Usd Million)
Table 211 Germany: Immunohistochemistry Market For Equipment, By Type, 2021–2028 (Usd Million)
Table 212 Germany: Immunohistochemistry Market For Kits, By Type, 2021–2028 (Usd Million)
Table 213 Germany: Immunohistochemistry Market, By Application, 2021–2028 (Usd Million)
Table 214 Germany: Immunohistochemistry Market For Diagnostic Applications, By Disease, 2021–2028 (Usd Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings